Pfizer.Inc, Amgen, Inc., Innovent Biologics, Inc., PegBio Co., Ltd., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Zealand Pharma, Moderna, Hanmi Science.
A study done in 2022 by the Institute for Clinical and Economic Review found that the cost associated with cardiovascular risks does not decrease with the inclusion of GLP-1s in a drug formulary when used for weight loss (as initially thought)
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: a post hoc analysis of the FIGHT trial
Ozempic and Wegovy have the same active ingredient (semaglutide) though they are sometimes administered at different doses
all findings remain investigational